Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Eddie Vedder, Hozier, Tom Holland and Colin Farrell Help Raise Over $3 Million for EB Research Partnership at New York Gala

      EB Research Partnership logo

      News provided by

      EB Research Partnership

      Nov 20, 2026, 13:00 ET

      Share this article

      Share this article


      Nearly 700 guests came together for a night of music, scientific progress and a shared determination to cure Epidermolysis Bullosa.

      NEW YORK, Nov. 20, 2026 /PRNewswire/ -- Nearly 700 people gathered at Pier Sixty in New York City on November 11 with one goal: to accelerate treatments and a cure for EB.

      By the end of the night, they had raised more than $3 million.

      From left to right: Michael Hund, CEO of EB Research Partnership; Olivia Vedder; Hozier; Eddie Vedder and Jill Vedder, co-founders of EB Research Partnership; and Colin Farrell at Venture Into Cures.
      Photo credit: Sachyn Mital
      From left to right: Michael Hund, CEO of EB Research Partnership; Olivia Vedder; Hozier; Eddie Vedder and Jill Vedder, co-founders of EB Research Partnership; and Colin Farrell at Venture Into Cures. Photo credit: Sachyn Mital
      From left to right: Jill Vedder, Robbie Twible, Eddie Vedder, Kalilla Dilgen, Chris Ulmer, Faye Dilgen and Teague Dilgen during the John Hudson Ambassadorship Award presentation at Venture Into Cures. Photo credit: Sachyn Mital
      From left to right: Jill Vedder, Robbie Twible, Eddie Vedder, Kalilla Dilgen, Chris Ulmer, Faye Dilgen and Teague Dilgen during the John Hudson Ambassadorship Award presentation at Venture Into Cures. Photo credit: Sachyn Mital
      From left to right: Sean Casey, Dr. Jeff Heddles, Elodie Kubik, Marc Seidner and event host Liz Trinnear celebrate the presentation of the
      Venture Into Cures Leadership Awards, recognizing Dr. Heddles and Seidner for their dedication to advancing EB Research Partnership’s mission. Photo credit: Yekaterina Gyadu
      From left to right: Sean Casey, Dr. Jeff Heddles, Elodie Kubik, Marc Seidner and event host Liz Trinnear celebrate the presentation of the Venture Into Cures Leadership Awards, recognizing Dr. Heddles and Seidner for their dedication to advancing EB Research Partnership’s mission. Photo credit: Yekaterina Gyadu
      From left to right: Michael Hund, CEO of EB Research Partnership; Olivia Vedder; Hozier; Eddie Vedder and Jill Vedder, co-founders of EB Research Partnership; and Colin Farrell at Venture Into Cures.
  Photo credit: Sachyn Mital From left to right: Jill Vedder, Robbie Twible, Eddie Vedder, Kalilla Dilgen, Chris Ulmer, Faye Dilgen and Teague Dilgen during the John Hudson Ambassadorship Award presentation at Venture Into Cures. Photo credit: Sachyn Mital From left to right: Sean Casey, Dr. Jeff Heddles, Elodie Kubik, Marc Seidner and event host Liz Trinnear celebrate the presentation of the
  Venture Into Cures Leadership Awards, recognizing Dr. Heddles and Seidner for their dedication to advancing EB Research Partnership’s mission. Photo credit: Yekaterina Gyadu

      Nearly 700 guests raised over $3 million for EB research as Eddie Vedder welcomed surprise guest Hozier onstage.

      Post this

      The event was Venture Into Cures, the signature gala of EB Research Partnership (EBRP), a nonprofit dedicated to curing epidermolysis bullosa (EB). Often called "Butterfly Disease," EB is a rare and life-threatening genetic condition that makes skin so fragile it can blister and tear from the slightest touch. While there is still no cure, breakthroughs in research and new treatments are bringing hope to families living with the disease.

      EBRP co-founders Jill and Eddie Vedder stood alongside families living with EB, world-class scientists and leaders from healthcare, finance and industry, all united by the belief that EB will be cured.

      "We have reached a remarkable moment in EB, progress that once seemed impossible is now happening before our eyes. We have gone from zero FDA-approved treatments to three, while clinical trials have increased 25-fold. Venture Into Cures is more than a celebration of how far we've come, it is a declaration that we are not slowing down. Together, we will keep pushing the boundaries of what is possible until treatments and cures reach every patient and family who needs them," said Michael Hund, CEO of EBRP.

      The evening's biggest musical moment came when Eddie Vedder introduced a surprise guest: Hozier. The Irish singer-songwriter took the stage in support of EBRP and its mission to cure EB, delivering a three-song performance that brought the house down.

      The program also featured comedian Sam Morril, who opened the evening, and television personality and etalk correspondent Liz Trinnear, who lives with EB simplex and served as host. Longtime EBRP supporter Tom Holland, who hosted the gala in 2021, delivered a personal video message introducing the evening's impact film.

      Academy Award-nominated actor Colin Farrell joined guests in support of the EB community. His upcoming documentary, The Slightest Touch, explores his friendship with EB advocate Emma Fogarty and premieres November 25 on HBO Max. The film continues the momentum generated by Matter of Time, the Netflix documentary that brought EBRP's work and the search for a cure to audiences around the world.

      The night's biggest moments

      • Archer's story. Host Liz Trinnear introduced Archer and his dad, Kirk Brazeau, whose family shared their life with EB in a short film.
      • Celebrating scientific breakthroughs. Introduced by Hodges Caldwell Jr. and Vanessa Leinert, Dr. Jean Tang of Stanford University presented the Innovation & Impact Award to Children's Hospital Colorado, accepted by Dr. James Feinstein, and the University of Colorado Anschutz, accepted by Dr. Ganna Bilousova. CU Anschutz is pioneering gene-corrected stem cell therapies for EB, and Children's Hospital Colorado is leading research to better detect and treat aggressive skin cancers in people living with EB.
      • Honoring John Hudson. In a moving tribute led by Chris Ulmer, founder of Special Books by Special Kids, EBRP Board Member Faye Dilgen honored her son, John Hudson Dilgen, who lived with EB and passed away earlier this year. One of the EB community's most powerful voices, John Hudson reached millions and inspired more than $720,000 in support of EB research. Faye presented the award named in his honor, the John Hudson Ambassadorship Award, to Robbie Twible. Robbie, who also lives with EB, carries that spirit forward, using his voice to raise awareness and build a brighter future for everyone living with EB.
      • A surprise for Faye. EBRP Co-Founder and Chairwoman Jill Vedder then presented Faye with a second John Hudson Ambassadorship Award for her relentless commitment to the EB community.
      • The paddles went up. Guests gave over $1.3 million during the paddle raise and the live auction of two guitars signed by Eddie Vedder and his Pearl Jam bandmates.
      • Celebrating leadership. Three Venture Into Cures Leadership Awards honored commitment to expanding EBRP's mission and bringing new supporters into the space. Carl Hess, CEO of Willis Towers Watson, presented to his colleague Glenn McGrath, the firm's Executive Vice President. Elodie Kubik presented to Marc Seidner, PIMCO investment leader and EBRP Board Member, and Dr. Jeff Heddles, philanthropist and EB research advocate. A young girl living with EB, Elodie is the inspiration behind Plunge for Elodie, a global polar plunge that raises awareness for EB. Former MLB All-Star Sean Casey joined them on stage with a playful surprise, an EBRP Speedo for each honoree and an invitation to take the Plunge for Elodie in 2027.
      • Remembering Ari Deshe. The night paid tribute to the late Ari Deshe, a longtime EBRP Board Member born with EB simplex, whose leadership helped build the foundation for today's progress.
      • A closing for the ages. Eddie Vedder introduced surprise guest Hozier to perform a set of songs. His performance brought one of music's most celebrated voices to the EB community and a global spotlight to a disease too few people know.
      • An after-party to remember. EBRP brought DJ Santy Monarka all the way from Bogotá, Colombia, for a special after-party performance. A talented young DJ living with EB, Santy was joined by his friend and collaborator, violinist and singer Nicolas Cordoba Shaw. Together they brought vibrant energy to the celebration and kept the dance floor full.

      "Not long ago, families living with EB were told science had nothing to offer them. Today we have approved treatments and a pipeline full of promise, because this community funded the work before anyone else would. Children's Hospital Colorado and CU Anschutz show what's possible when bold science and compassionate care move together," said Dr. Jean Tang.

      "John Hudson used his voice to help the world understand EB. Watching Robbie carry that same spirit forward means more than I can say. John Hudson's greatest wish was that the children who come after him would never know the pain he lived with, and tonight this room brought that wish closer," said Faye Dilgen.

      "What makes EB Research Partnership extraordinary is its ability to unite groundbreaking science with an unwavering commitment to the families at the heart of this mission. Every individual I've introduced to this organization has come away with a profound understanding of both the urgency and the opportunity before us. I'm committed to seeing this work through until EB is cured," said Glenn McGrath.

      A model built to cure

      EBRP exists to cure EB. Founded in 2010 by families alongside Jill and Eddie Vedder, it is the largest global nonprofit dedicated to EB research. EBRP backs the most promising science early, when funding matters most, and pushes it toward patients fast.

      Since 2010, EBRP has raised over $96 million, funded over 200 research projects across 22 countries, and active EB clinical trials have grown from 2 to 50. In 2023, the FDA approved the first treatments ever for EB. Today there are three, two of which were built on science EBRP helped fund early.

      Breakthrough science often stalls for lack of early funding. EBRP's unique Venture Philanthropy model was built to change that. Unlike traditional grantmaking, EBRP takes a financial interest in the research it funds. When a therapy succeeds, the return flows back into new research until there is a cure, so every gift keeps working long after it's given. Forbes, Harvard Business School, MIT Solve, the Milken Institute and Stanford Social Innovation Review have all recognized the model for its innovative technique.

      What works for EB can work for more than 10,000 rare diseases affecting 400 million people worldwide, 95% of which still lack an approved treatment. That model is already scaling. Rare Ventures, launched with up to $25 million from the Richard King Mellon Foundation, unites EBRP with UPMC Children's Hospital of Pittsburgh, UPMC Vision Institute, Carnegie Mellon University, Stanford Medicine and ElevateBio to speed therapies for rare diseases.

      Venture Into Cures was presented by Willis Towers Watson (WTW) and The McGrath Family, with generous support from Titanium sponsors The Seidner Family and Turtle Pond Foundation and Platinum sponsors The Finkelstein Family and The Oros Family. Thank you to all of the event's Partners in Flight, listed at ebresearch.org/vic2026.

      About EB Research Partnership

      Founded in 2010 by a group of families and Jill and Eddie Vedder, EB Research Partnership (EBRP) is the largest global nonprofit dedicated to curing epidermolysis bullosa (EB), a rare genetic disease that makes skin blister and tear at the slightest touch. Through its venture philanthropy model, EBRP funds the most promising science early and reinvests any return from successful therapies into more research until there is a cure. Its approach is a blueprint for thousands of other rare diseases. With offices in the US and Australia, EBRP directs 100% of every gift to research, thanks to angel donors who cover operations. Learn more at www.ebresearch.org.

      Photos and video are available at https://drive.google.com/drive/folders/1cprIl0lQ4H_n68gcc4lHPhq0R2sKh4Ul?usp=sharing

      SOURCE EB Research Partnership

      Modal title

      Also from this source

      Eleonora Buratto appointed Ambassador for EB Research Partnership

      Eleonora Buratto appointed Ambassador for EB Research Partnership

      It was fate that brought internationally acclaimed soprano Eleonora Buratto and EB Research Partnership (EBRP) together. What began with her role...

      9th Annual Plunge for Elodie Poised to Surpass $3.5 Million Raised for EB Research Partnership

      9th Annual Plunge for Elodie Poised to Surpass $3.5 Million Raised for EB Research Partnership

      EB Research Partnership (EBRP) announces the 9th Annual Plunge for Elodie, taking place March–May 2026, with events across 4 continents. What began...

      More Releases From This Source

      Explore

      Biotechnology

      Biotechnology

      Health Care & Hospitals

      Health Care & Hospitals

      Corporate Social Responsibility

      Corporate Social Responsibility

      Not For Profit

      Not For Profit

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.